Stabilization of recombinantly expressed proteins.
Matthiesen
F
F
Novo Nordisk A/S, Nova Allé, Bagsvoerd, Denmark.
Hejnaes
K R
KR
Skriver
L
L
D000595:Amino Acid Sequence; D000818:Animals; D003001:Cloning, Molecular / Q000379:methods; D004220:Disulfides; D004355:Drug Stability; D004795:Enzyme Stability; D004926:Escherichia coli; D005934:Glucagon / Q000096:biosynthesis / Q000737:chemistry* / Q000302:isolation & purification; D005968:Glutamate Decarboxylase / Q000096:biosynthesis / Q000737:chemistry* / Q000302:isolation & purification; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000096:biosynthesis / Q000737:chemistry* / Q000302:isolation & purification; D008969:Molecular Sequence Data; D011487:Protein Conformation; D011489:Protein Denaturation; D017510:Protein Folding; D017433:Protein Structure, Secondary; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000737:chemistry* / Q000302:isolation & purification; D013816:Thermodynamics
D004220:Disulfides; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D005934:Glucagon; D005968:Glutamate Decarboxylase